Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen

Anitha, 2011, Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells, Carbohydr. Polym., 83, 452, 10.1016/j.carbpol.2010.08.008 Barbieri, 2013, Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake, J. Control. Release, 167, 276, 10.1016/j.jconrel.2013.02.009 Breedveld, 2006, Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs, Trends Pharmacol. Sci., 27, 17, 10.1016/j.tips.2005.11.009 Cavallaro, 2004, Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro evaluation studies, Macromol. Biosci., 4, 1028, 10.1002/mabi.200400089 Chawla, 2002, Biodegradable poly (ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen, Int. J. Pharm., 249, 127, 10.1016/S0378-5173(02)00483-0 Dash, 2007, Evaluation of hepatoprotective and antioxidant activity of Ichnocarpus frutescens (Linn.) R. Br. on paracetamol-induced hepatotoxicity in rats, Trop. J. Pharm. Res., 6, 755, 10.4314/tjpr.v6i3.14656 Fariss, 1993, Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol, Environ. Health Perspect., 101, 528, 10.1289/ehp.93101528 Fornander, 1993, Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer, J. Natl. Cancer Inst., 85, 1850, 10.1093/jnci/85.22.1850 Gao, 2002, Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs, Nano Lett., 2, 979, 10.1021/nl025604a Gong, 2012, Polymeric micelles drug delivery system in oncology, J. Control. Release, 159, 312, 10.1016/j.jconrel.2011.12.012 Iusuf, 2011, P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetration, J. Pharmacol. Exp. Ther., 337, 710, 10.1124/jpet.110.178301 Jain, 2014, Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization, Pharm. Res., 31, 923, 10.1007/s11095-013-1213-2 Jena, 2016, Polymeric micelles of amphiphilic graft copolymer of α-tocopherol succinate-g-carboxymethyl chitosan for tamoxifen delivery: synthesis, characterization and in vivo pharmacokinetic study, Carbohydr. Polym., 151, 1162, 10.1016/j.carbpol.2016.06.078 Jena, 2017, Polymeric micelles: a promising tool for tamoxifen delivery in cancer?, Ther. Deliv., 8, 109, 10.4155/tde-2016-0083 Jena, 2014, Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability, Int. J. Pharm., 473, 1, 10.1016/j.ijpharm.2014.06.056 Jena, 2015, Modulation of tamoxifen-induced hepatotoxicity by tamoxifen-phospholipid complex, J. Pharm. Pharmacol., 67, 1198, 10.1111/jphp.12422 Johnson, 2004, Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen, Breast Cancer Res. Treat., 85, 151, 10.1023/B:BREA.0000025406.31193.e8 Jordan, 2003, Tamoxifen: a most unlikely pioneering medicine, Nat. Rev. Drug Discov., 2, 205, 10.1038/nrd1031 Joshi, 2013, Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel, Biomacromolecules, 14, 2272, 10.1021/bm400406x Lin, 2005, Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells, Biomacromolecules, 6, 1104, 10.1021/bm049312a Lukyanov, 2004, Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs, Adv. Drug Deliv. Rev., 56, 1273, 10.1016/j.addr.2003.12.004 Ma, 2003, Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles, Pharm. Res., 20, 1812, 10.1023/B:PHAM.0000003379.76417.3e Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Meier, 1998, Tamoxifen and risk of idiopathic venous thromboembolism, Br. J. Clin. Pharmacol., 45, 608, 10.1046/j.1365-2125.1998.00733.x Nam, 2009, Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles, J. Control. Release, 135, 259, 10.1016/j.jconrel.2009.01.018 Nie, 2010, Understanding and overcoming major barriers in cancer nanomedicine, Nanomedicine, 5, 523, 10.2217/nnm.10.23 Palmberger, 2008, Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir, Int. J. Pharm., 348, 54, 10.1016/j.ijpharm.2007.07.004 Shete, 2013, Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization, Int. J. Pharm., 454, 573, 10.1016/j.ijpharm.2013.03.034 Shi, 2011, Exploring N-imidazolyl-O-carboxymethyl chitosan for high performance gene delivery, Biomacromolecules, 13, 146, 10.1021/bm201380e Shin, 2006, Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats, Int. J. Pharm., 313, 144, 10.1016/j.ijpharm.2006.01.028 Thanou, 2001, Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo, J. Pharm. Sci., 90, 38, 10.1002/1520-6017(200101)90:1<38::AID-JPS5>3.0.CO;2-3 Thompson, 1991, Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea, Cancer Res., 51, 3411 Traber, 1995, Vitamin E: beyond antioxidant function, Am. J. Clin. Nutr., 62, 1501S, 10.1093/ajcn/62.6.1501S Vigushin, 2001, Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo, Clin. Cancer Res., 7, 971 Wahlang, 2011, Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model, Eur. J. Pharm. Biopharm., 77, 275, 10.1016/j.ejpb.2010.12.006 Wu, 2009, The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor α for degradation in breast cancer cells, Cancer Res., 69, 1722, 10.1158/0008-5472.CAN-08-3933